Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Extending and maintaining micropore viability of microneedle treated skin with lipid biosynthesis inhibitors for sustained drug delivery

Extending and maintaining micropore viability of microneedle treated skin with lipid biosynthesis inhibitors for sustained drug delivery

US Patent 10022366 · Granted Jul 17, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Abuse deterrent opioid/opioid-antagonist transdermal patch2019
Oxymorphone transdermal patch2018
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydro2018
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydro2017
Compounds including Cox inhibitor moiety and enhanced delivery of active drugs u2017
Compounds including Cox inhibitor moiety and enhanced delivery of active drugs u2017
Use of cannabidiol prodrugs in topical and transdermal administration with micro2017
Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydro2015
Enhancing transdermal delivery of opioid antagonists and agonists using codrugs 2014
Abuse deterrent transdermal formulations of opiate agonists and agonist-antagoni2013
Transdermal delivery of cannabidiol2013
Transdermal delivery of cannabidiol2013